Digital Health Technology Assessment – Challenges and opportunities ... Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster
Digital AI-powered drug discovery is outpacing regulators, with Eric... During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Digital Sponsored Axtria Ignite 2025: AI-powered pharma leadership and transfo... Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated Axtria Ignite 2025 conference, set to take place 4th-5th June at the
Digital From signatures to success: How digital consent accelerates ... Informed consent is a foundational element of every clinical trial.
Digital AI in drug development: The real hurdle is implementation Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.
Digital Sponsored 12 Questions with Michael Müller-Peltzer Michael Müller-Peltzer leads the European strategy for Vault CRM Campaign Manager at Veeva Systems.
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.